188 related articles for article (PubMed ID: 24037776)
1. Opposite effects of tamoxifen on metabolic syndrome-induced bladder and prostate alterations: a role for GPR30/GPER?
Comeglio P; Morelli A; Cellai I; Vignozzi L; Sarchielli E; Filippi S; Maneschi E; Corcetto F; Corno C; Gacci M; Vannelli GB; Maggi M
Prostate; 2014 Jan; 74(1):10-28. PubMed ID: 24037776
[TBL] [Abstract][Full Text] [Related]
2. Tamoxifen regulation of bone growth and endocrine function in the ovariectomized rat: discrimination of responses involving estrogen receptor α/estrogen receptor β, G protein-coupled estrogen receptor, or estrogen-related receptor γ using fulvestrant (ICI 182780).
Fitts JM; Klein RM; Powers CA
J Pharmacol Exp Ther; 2011 Jul; 338(1):246-54. PubMed ID: 21464335
[TBL] [Abstract][Full Text] [Related]
3. Regulation of ERRalpha gene expression by estrogen receptor agonists and antagonists in SKBR3 breast cancer cells: differential molecular mechanisms mediated by g protein-coupled receptor GPR30/GPER-1.
Li Y; Birnbaumer L; Teng CT
Mol Endocrinol; 2010 May; 24(5):969-80. PubMed ID: 20211987
[TBL] [Abstract][Full Text] [Related]
4. Testosterone and farnesoid X receptor agonist INT-747 counteract high fat diet-induced bladder alterations in a rabbit model of metabolic syndrome.
Morelli A; Comeglio P; Filippi S; Sarchielli E; Cellai I; Vignozzi L; Yehiely-Cohen R; Maneschi E; Gacci M; Carini M; Adorini L; Vannelli GB; Maggi M
J Steroid Biochem Mol Biol; 2012 Oct; 132(1-2):80-92. PubMed ID: 22406511
[TBL] [Abstract][Full Text] [Related]
5. Tamoxifen and ICI 182,780 activate hypothalamic G protein-coupled estrogen receptor 1 to rapidly facilitate lordosis in female rats.
Long N; Long B; Mana A; Le D; Nguyen L; Chokr S; Sinchak K
Horm Behav; 2017 Mar; 89():98-103. PubMed ID: 28063803
[TBL] [Abstract][Full Text] [Related]
6. Sex steroid receptors in male human bladder: expression and biological function.
Chavalmane AK; Comeglio P; Morelli A; Filippi S; Fibbi B; Vignozzi L; Sarchielli E; Marchetta M; Failli P; Sandner P; Saad F; Gacci M; Vannelli GB; Maggi M
J Sex Med; 2010 Aug; 7(8):2698-713. PubMed ID: 20412431
[TBL] [Abstract][Full Text] [Related]
7. Acquisition of epithelial-mesenchymal transition phenotype in the tamoxifen-resistant breast cancer cell: a new role for G protein-coupled estrogen receptor in mediating tamoxifen resistance through cancer-associated fibroblast-derived fibronectin and β1-integrin signaling pathway in tumor cells.
Yuan J; Liu M; Yang L; Tu G; Zhu Q; Chen M; Cheng H; Luo H; Fu W; Li Z; Yang G
Breast Cancer Res; 2015 May; 17(1):69. PubMed ID: 25990368
[TBL] [Abstract][Full Text] [Related]
8. Does GPER Really Function as a G Protein-Coupled Estrogen Receptor
Luo J; Liu D
Front Endocrinol (Lausanne); 2020; 11():148. PubMed ID: 32296387
[TBL] [Abstract][Full Text] [Related]
9. Continuous Exposure of Breast Cancer Cells to Tamoxifen Upregulates GPER-1 and Increases Cell Proliferation.
Molina L; Bustamante F; Ortloff A; Ramos I; Ehrenfeld P; Figueroa CD
Front Endocrinol (Lausanne); 2020; 11():563165. PubMed ID: 33117280
[TBL] [Abstract][Full Text] [Related]
10. G-protein-coupled estrogen receptor GPER-1 expression in hormone receptor-positive breast cancer is associated with poor benefit of tamoxifen.
Ignatov T; Claus M; Nass N; Haybaeck J; Seifert B; Kalinski T; Ortmann O; Ignatov A
Breast Cancer Res Treat; 2019 Feb; 174(1):121-127. PubMed ID: 30478785
[TBL] [Abstract][Full Text] [Related]
11. Estrogen mediates metabolic syndrome-induced erectile dysfunction: a study in the rabbit.
Vignozzi L; Filippi S; Comeglio P; Cellai I; Morelli A; Marchetta M; Maggi M
J Sex Med; 2014 Dec; 11(12):2890-902. PubMed ID: 25243860
[TBL] [Abstract][Full Text] [Related]
12. GPER-1 and estrogen receptor-β ligands modulate aldosterone synthesis.
Caroccia B; Seccia TM; Campos AG; Gioco F; Kuppusamy M; Ceolotto G; Guerzoni E; Simonato F; Mareso S; Lenzini L; Fassina A; Rossi GP
Endocrinology; 2014 Nov; 155(11):4296-304. PubMed ID: 25167221
[TBL] [Abstract][Full Text] [Related]
13. Estrogen receptor-α is a key mediator and therapeutic target for bladder complications of benign prostatic hyperplasia.
Nicholson TM; Moses MA; Uchtmann KS; Keil KP; Bjorling DE; Vezina CM; Wood RW; Ricke WA
J Urol; 2015 Feb; 193(2):722-9. PubMed ID: 25167991
[TBL] [Abstract][Full Text] [Related]
14. Stimulating the GPR30 estrogen receptor with a novel tamoxifen analogue activates SF-1 and promotes endometrial cell proliferation.
Lin BC; Suzawa M; Blind RD; Tobias SC; Bulun SE; Scanlan TS; Ingraham HA
Cancer Res; 2009 Jul; 69(13):5415-23. PubMed ID: 19549922
[TBL] [Abstract][Full Text] [Related]
15. Lack of G protein-coupled estrogen receptor (GPER) in the plasma membrane is associated with excellent long-term prognosis in breast cancer.
Sjöström M; Hartman L; Grabau D; Fornander T; Malmström P; Nordenskjöld B; Sgroi DC; Skoog L; Stål O; Leeb-Lundberg LM; Fernö M
Breast Cancer Res Treat; 2014 May; 145(1):61-71. PubMed ID: 24715381
[TBL] [Abstract][Full Text] [Related]
16. MiR-206 inhibits estrogen signaling and ovarian cancer cell migration without affecting GPER.
Boscaro C; Ramaschi GE; Trevisi L; Cignarella A; Bolego C
Life Sci; 2023 Nov; 333():122135. PubMed ID: 37778413
[TBL] [Abstract][Full Text] [Related]
17. Deciphering the GPER/GPR30-agonist and antagonists interactions using molecular modeling studies, molecular dynamics, and docking simulations.
Méndez-Luna D; Martínez-Archundia M; Maroun RC; Ceballos-Reyes G; Fragoso-Vázquez MJ; González-Juárez DE; Correa-Basurto J
J Biomol Struct Dyn; 2015; 33(10):2161-72. PubMed ID: 25587872
[TBL] [Abstract][Full Text] [Related]
18. The G-protein-coupled estrogen receptor GPER in health and disease.
Prossnitz ER; Barton M
Nat Rev Endocrinol; 2011 Aug; 7(12):715-26. PubMed ID: 21844907
[TBL] [Abstract][Full Text] [Related]
19. G protein-coupled estrogen receptor (GPER) mediates NSCLC progression induced by 17β-estradiol (E2) and selective agonist G1.
Liu C; Liao Y; Fan S; Tang H; Jiang Z; Zhou B; Xiong J; Zhou S; Zou M; Wang J
Med Oncol; 2015 Apr; 32(4):104. PubMed ID: 25744245
[TBL] [Abstract][Full Text] [Related]
20. Estrogen-mediated inactivation of FOXO3a by the G protein-coupled estrogen receptor GPER.
Zekas E; Prossnitz ER
BMC Cancer; 2015 Oct; 15():702. PubMed ID: 26470790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
